Shigellosis

A Human Challenge Study to Assess Protection of a Shigella Tetravalent Bioconjugate Vaccine

Study to Expand Safety and Immunogenicity Data With Shigella Bioconjugate Vaccine (Shigella4V2) in 9-month-old Infants.

Tebipenem Trial in Children With Shigellosis

Safety and Efficacy of the Bacteriophage Preparation, ShigActive™, in a Human Experimental Model of Shigellosis

Shigella Sonnei 53G Human Infection Study in Kenyan Adults

Controlled Human Infection Model Challenge/Rechallenge

InvaplexAR-Detox and DmLT Adjuvant in the Netherlands and Zambia

A Study to Determine If a New Shigella Vaccine is Safe, Induces Immunity and The Best Dose Among Kenyan Infants

Ciprofloxacin Versus Azithromycin for Children Hospitalised With Dysentery

Efficacy, Immunogenicity and Safety of S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 6 Months to 5 Years

Safety Study of Inactivated Shigella Whole Cell Vaccine in Adults

Safety and Immunogenicity of Artificial Invaplex (Shigella Flexneri 2a InvaplexAR)

Phase 2b Challenge Study With the Bioconjugate Vaccine Flexyn2a

Shigella Sonnel O-SPC/rBRU Conjugate Vaccine

A Phase 1, Dose Escalation Study, to Evaluate a New Shigella Sonnei Vaccine in Healthy Adults.

SF2a-TT15 Conjugate Vaccine in Healthy Adult Volunteers

Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection

Shigella Sonnei OSPC-rDT Conjugate Vaccine

Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive Disorders

Evaluate a New Shigella Sonnei Vaccine Administered Either by Intradermal, Intranasal or Intramuscular Route in Healthy Adults